Jazz Pharmaceuticals plc — Director's Dealing 2014

Sep 10, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-09-08

Reporting Person: WILSON KAREN J (SVP, Finance & PAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-08	Ordinary Shares	M	2500	$27.46	Acquired	24213	Direct
2014-09-08	Ordinary Shares	S	2500	$170.00	Disposed	21713	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-09-08	Incentive Stock Option (right to buy)	$27.46	M	2500	Disposed	2021-03-09	Ordinary Shares (2500)	Direct

Footnotes

F1: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: Following the reported transaction, the remaining ordinary shares subject to this option are vested with respect to 5,012 shares and will vest with respect to 911 shares in equal monthly installments from October 7, 2014 to December 7, 2014 and with respect to 2,084 shares in equal monthly installments from January 7, 2015 to February 7, 2015.